DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
CESIUM CS-131
1
Small molecule
Investigational
Unknown
Unknown
Head and Neck Neoplasms; Carcinoma, Squamous Cell
Unknown
CESIUM CS-131
×
Maximum Phase:
1
First Approval:
None
UNII:
BKV67W3IO8
Molecule Type:
Small molecule
Molecular Formula:
Cs
Molecular Weight:
130.91
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CLENBUTEROL
1
Small molecule
Investigational
Unknown
Unknown
Amyotrophic Lateral Sclerosis; Glycogen Storage Disease Type II; Parkinson Disease; Lung Diseases, Obstructive
Beta-2 adrenergic receptor agonist
CLENBUTEROL
×
Maximum Phase:
1
First Approval:
None
UNII:
XTZ6AXU7KN
Molecule Type:
Small molecule
Molecular Formula:
C12H18Cl2N2O
Molecular Weight:
277.2
AlogP:
3.0
PSA:
58.28
HBD:
3.0
HBA:
#RotB:
3.0
Source:
VLX-1005
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
VLX-1005
×
Maximum Phase:
1
First Approval:
None
UNII:
JKU4XCC48Y
Molecule Type:
Small molecule
Molecular Formula:
C21H19N3O4S2
Molecular Weight:
441.53
AlogP:
4.42
PSA:
100.55
HBD:
3.0
HBA:
#RotB:
7.0
Source:
BMS-698769
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Hepatocyte growth factor receptor inhibitor
BMS-698769
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-184476
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
BMS-184476
×
Maximum Phase:
1
First Approval:
None
UNII:
3811W2NBZ8
Molecule Type:
Small molecule
Molecular Formula:
C49H55NO14S
Molecular Weight:
914.04
AlogP:
5.08
PSA:
210.29
HBD:
3.0
HBA:
#RotB:
13.0
Source:
MK-0752
1
Small molecule
Investigational
Unknown
Unknown
Central Nervous System Neoplasms; Neoplasms
Unknown
MK-0752
×
Maximum Phase:
1
First Approval:
None
UNII:
9JD9B4S53T
Molecule Type:
Small molecule
Molecular Formula:
C21H21ClF2O4S
Molecular Weight:
442.91
AlogP:
5.34
PSA:
71.44
HBD:
1.0
HBA:
#RotB:
6.0
Source:
ORE-1001
1
Small molecule
Investigational
Unknown
Unknown
Colitis, Ulcerative
Unknown
ORE-1001
×
Maximum Phase:
1
First Approval:
None
UNII:
4LD0ZHV25K
Molecule Type:
Small molecule
Molecular Formula:
C19H23Cl2N3O4
Molecular Weight:
428.32
AlogP:
3.32
PSA:
104.45
HBD:
3.0
HBA:
#RotB:
10.0
Source:
ZOTATIFIN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Severe Acute Respiratory Syndrome
Unknown
ZOTATIFIN
×
Maximum Phase:
1
First Approval:
None
UNII:
2EWN8Z05CN
Molecule Type:
Small molecule
Molecular Formula:
C28H29N3O5
Molecular Weight:
487.56
AlogP:
2.78
PSA:
108.07
HBD:
2.0
HBA:
#RotB:
6.0
Source:
8-CHLOROADENOSINE
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Unknown
8-CHLOROADENOSINE
×
Maximum Phase:
1
First Approval:
None
UNII:
PA05MFH3I7
Molecule Type:
Small molecule
Molecular Formula:
C10H12ClN5O4
Molecular Weight:
301.69
AlogP:
-1.33
PSA:
139.54
HBD:
4.0
HBA:
#RotB:
2.0
Source:
AC-1204
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AC-1204
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CIPRALISANT MALEATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Histamine H3 receptor agonist
CIPRALISANT MALEATE
×
Maximum Phase:
1
First Approval:
None
UNII:
7ENI812SZS
Molecule Type:
Small molecule
Molecular Formula:
C18H24N2O4
Molecular Weight:
332.4
AlogP:
3.34
PSA:
28.68
HBD:
1.0
HBA:
#RotB:
2.0
Source:
BIIF 1149 BS
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BIIF 1149 BS
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DETROTHYRONINE
1
Small molecule
Investigational
Unknown
Unknown
Heart Failure
Unknown
DETROTHYRONINE
×
Maximum Phase:
1
First Approval:
None
UNII:
46XII7C16X
Molecule Type:
Small molecule
Molecular Formula:
C15H12I3NO4
Molecular Weight:
650.98
AlogP:
3.95
PSA:
92.78
HBD:
3.0
HBA:
#RotB:
5.0
Source:
VS-4718
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Biphenotypic, Acute; Leukemia, Myeloid, Acute; Pancreatic Neoplasms
Focal adhesion kinase 1 inhibitor
VS-4718
×
Maximum Phase:
1
First Approval:
None
UNII:
L2BD0MW4OL
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FEDOVAPAGON
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FEDOVAPAGON
×
Maximum Phase:
1
First Approval:
None
UNII:
VX2GBO4I0V
Molecule Type:
Small molecule
Molecular Formula:
C27H34N4O3
Molecular Weight:
462.59
AlogP:
3.74
PSA:
72.96
HBD:
1.0
HBA:
#RotB:
4.0
Source:
BLXA4
1
Small molecule
Investigational
Unknown
Unknown
Inflammation
Unknown
BLXA4
×
Maximum Phase:
1
First Approval:
None
UNII:
LXE89WJ787
Molecule Type:
Small molecule
Molecular Formula:
C22H32O5
Molecular Weight:
376.49
AlogP:
3.63
PSA:
97.99
HBD:
4.0
HBA:
#RotB:
13.0
Source:
R(+)XK469
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Neuroblastoma
Unknown
R(+)XK469
×
Maximum Phase:
1
First Approval:
None
UNII:
8VSJ573G09
Molecule Type:
Small molecule
Molecular Formula:
C17H13ClN2O4
Molecular Weight:
344.75
AlogP:
3.93
PSA:
81.54
HBD:
1.0
HBA:
#RotB:
5.0
Source:
TECHNETIUM TC-99M PERTECHNETATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
TECHNETIUM TC-99M PERTECHNETATE
×
Maximum Phase:
1
First Approval:
None
UNII:
PPP8783IQ1
Molecule Type:
Small molecule
Molecular Formula:
HO4Tc
Molecular Weight:
163.91
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
RODATRISTAT ETHYL
1
Small molecule
Investigational
Unknown
Unknown
Hypertension, Pulmonary
Tryptophan 5-hydroxylase 1 inhibitor
RODATRISTAT ETHYL
×
Maximum Phase:
1
First Approval:
None
UNII:
507FY6OL37
Molecule Type:
Small molecule
Molecular Formula:
C29H31ClF3N5O3
Molecular Weight:
590.05
AlogP:
5.57
PSA:
102.6
HBD:
2.0
HBA:
#RotB:
7.0
Source:
MLN-8054
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Colonic Neoplasms; Neoplasms; Pancreatic Neoplasms
Serine/threonine-protein kinase Aurora-A inhibitor
MLN-8054
×
Maximum Phase:
1
First Approval:
None
UNII:
BX854EHD63
Molecule Type:
Small molecule
Molecular Formula:
C25H15ClF2N4O2
Molecular Weight:
476.87
AlogP:
5.87
PSA:
87.47
HBD:
2.0
HBA:
#RotB:
4.0
Source:
RGB-286638
1
Small molecule
Investigational
Unknown
Unknown
Hematologic Neoplasms
Cyclin-dependent kinase 1 inhibitor
RGB-286638
×
Maximum Phase:
1
First Approval:
None
UNII:
1GAJ98SC2X
Molecule Type:
Small molecule
Molecular Formula:
C29H35N7O4
Molecular Weight:
545.64
AlogP:
2.42
PSA:
115.06
HBD:
3.0
HBA:
#RotB:
8.0
Source:
SC-43
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
SC-43
×
Maximum Phase:
1
First Approval:
None
UNII:
OT4AQX5MLU
Molecule Type:
Small molecule
Molecular Formula:
C21H13ClF3N3O2
Molecular Weight:
431.8
AlogP:
6.67
PSA:
74.15
HBD:
2.0
HBA:
#RotB:
4.0
Source:
NEOSAXITOXIN
1
Small molecule
Investigational
Unknown
Unknown
Pain
Unknown
NEOSAXITOXIN
×
Maximum Phase:
1
First Approval:
None
UNII:
6YRL8BWD9H
Molecule Type:
Small molecule
Molecular Formula:
C10H17N7O5
Molecular Weight:
315.29
AlogP:
-3.54
PSA:
193.75
HBD:
7.0
HBA:
#RotB:
2.0
Source:
D-FLUOROMETHYLTYROSINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
D-FLUOROMETHYLTYROSINE
×
Maximum Phase:
1
First Approval:
None
UNII:
GSM7N3U4J8
Molecule Type:
Small molecule
Molecular Formula:
C10H12FNO3
Molecular Weight:
213.21
AlogP:
0.95
PSA:
72.55
HBD:
2.0
HBA:
#RotB:
5.0
Source:
AR-42
1
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma
Unknown
AR-42
×
Maximum Phase:
1
First Approval:
None
UNII:
E0GG29V0AQ
Molecule Type:
Small molecule
Molecular Formula:
C18H20N2O3
Molecular Weight:
312.37
AlogP:
3.18
PSA:
78.43
HBD:
3.0
HBA:
#RotB:
5.0
Source:
SNX-001
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SNX-001
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-03814735
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Serine/threonine-protein kinase Aurora-A inhibitor
PF-03814735
×
Maximum Phase:
1
First Approval:
None
UNII:
6V5T4O5758
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LENRISPODUN
1
Small molecule
Investigational
Unknown
Unknown
Heart Failure, Systolic; Parkinson Disease; Schizophrenia
Unknown
LENRISPODUN
×
Maximum Phase:
1
First Approval:
None
UNII:
3GBO34D1BE
Molecule Type:
Small molecule
Molecular Formula:
C29H26FN7O
Molecular Weight:
507.57
AlogP:
5.06
PSA:
78.65
HBD:
1.0
HBA:
#RotB:
5.0
Source:
MOFAROTENE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Retinoid receptor modulator
MOFAROTENE
×
Maximum Phase:
1
First Approval:
None
UNII:
8K3CVY8F8V
Molecule Type:
Small molecule
Molecular Formula:
C29H39NO2
Molecular Weight:
433.64
AlogP:
6.31
PSA:
21.7
HBD:
0.0
HBA:
#RotB:
6.0
Source:
REBASTINIB
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasms
Tyrosine-protein kinase ABL inhibitor
REBASTINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
75017Q6I97
Molecule Type:
Small molecule
Molecular Formula:
C30H28FN7O3
Molecular Weight:
553.6
AlogP:
6.05
PSA:
123.06
HBD:
3.0
HBA:
#RotB:
6.0
Source:
MAVATREP
1
Small molecule
Investigational
Unknown
Unknown
Osteoarthritis, Knee
Vanilloid receptor antagonist
MAVATREP
×
Maximum Phase:
1
First Approval:
None
UNII:
F197218T99
Molecule Type:
Small molecule
Molecular Formula:
C25H21F3N2O
Molecular Weight:
422.45
AlogP:
6.65
PSA:
48.91
HBD:
2.0
HBA:
#RotB:
4.0
Source:
BMS-394136
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BMS-394136
×
Maximum Phase:
1
First Approval:
None
UNII:
M694U7167K
Molecule Type:
Small molecule
Molecular Formula:
C24H21Cl2FN4O
Molecular Weight:
471.36
AlogP:
5.98
PSA:
50.16
HBD:
1.0
HBA:
#RotB:
3.0
Source:
CI-988
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Cholecystokinin B receptor antagonist
CI-988
×
Maximum Phase:
1
First Approval:
None
UNII:
2637PDX9SI
Molecule Type:
Small molecule
Molecular Formula:
C35H42N4O6
Molecular Weight:
614.74
AlogP:
4.86
PSA:
149.62
HBD:
5.0
HBA:
#RotB:
12.0
Source:
NIKKOMYCIN Z
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
NIKKOMYCIN Z
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MK-8245
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
MK-8245
×
Maximum Phase:
1
First Approval:
None
UNII:
537E7QE8LX
Molecule Type:
Small molecule
Molecular Formula:
C17H16BrFN6O4
Molecular Weight:
467.26
AlogP:
2.36
PSA:
119.4
HBD:
1.0
HBA:
#RotB:
6.0
Source:
1
2
…
67
68
69
70
71
72
73
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA